Clinical Trials Logo

Clinical Trial Summary

Frailty is a state of health with predisposition to adverse events, morbidity and mortality. Frailty consists of weakness, slowness, low physical activity, exhaustion, and wasting. Frailty is associated with increased hospitalizations and death in lung disease. It is unknown if pulmonary rehabilitation will improve frailty markers.


Clinical Trial Description

Individuals referred to pulmonary rehabilitation will be examined for frailty markers. After completing pulmonary rehabilitation, the same tests will be performed. The effects of pulmonary rehabilitation will be examined. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02512874
Study type Interventional
Source Mayo Clinic
Contact
Status Completed
Phase N/A
Start date July 21, 2015
Completion date October 16, 2018

See also
  Status Clinical Trial Phase
Completed NCT01052298 - Study to Evaluate the Safety and Pharmacokinetics of Inhaled Ciprofloxacin in Patients With Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD) Phase 1